Treatment of Reactive Airways in an Asthmatic After Cleaning Solution Inhalation
Immediately administer high-dose nebulized beta-agonists (salbutamol 5 mg or terbutaline 10 mg) with oxygen, and give systemic corticosteroids (prednisolone 30-60 mg orally or hydrocortisone 200 mg IV) without delay. This represents acute severe asthma triggered by irritant exposure and requires aggressive treatment to prevent mortality 1, 2.
Initial Assessment and Severity Classification
First, objectively assess severity using peak expiratory flow (PEF) and clinical parameters:
Severe asthma features:
- Cannot complete sentences in one breath
- Pulse >110 beats/min
- Respirations >25 breaths/min
- PEF <50% predicted or personal best 2
Life-threatening features:
- PEF <33% predicted
- Silent chest, cyanosis, or feeble respiratory effort
- Exhaustion, confusion, altered consciousness
- Bradycardia or hypotension 1, 2
Immediate Treatment Protocol
First-Line Therapy (Within Minutes)
Oxygen: 40-60% via face mask to maintain SaO₂ >92% 2
Nebulized bronchodilators: Salbutamol 5 mg OR terbutaline 10 mg via oxygen-driven nebulizer 1, 2
Systemic corticosteroids immediately:
Reassess at 15-30 Minutes
If improving (PEF >50-75% predicted):
- Continue oxygen
- Continue nebulized β-agonist every 4 hours
- Continue prednisolone 30-60 mg daily 2
If NOT improving or life-threatening features:
- Increase nebulized β-agonist frequency to every 15-30 minutes
- Add ipratropium 0.5 mg to nebulizer (critical addition for severe cases) 1, 2
- Consider IV aminophylline 250 mg over 20 minutes (avoid if already on oral theophyllines) 1
- Alternative: IV salbutamol or terbutaline 250 µg over 10 minutes 1
Hospital Admission Criteria
Admit immediately if:
- Any life-threatening features present
- PEF remains <33% after initial treatment
- Features of severe asthma persist 15-30 minutes post-nebulization
- Patient seen in afternoon/evening (higher risk)
- History of previous severe attacks with rapid onset 1, 2
Special Considerations for Irritant-Induced Reactive Airways
This scenario represents Reactive Airways Dysfunction Syndrome (RADS) - asthma triggered by high-level irritant exposure without a latency period 3, 4, 5. Key points:
- Bronchial hyperresponsiveness may persist for months to years after the acute exposure 3, 5
- The patient may show marked epithelial damage and inflammatory cell infiltration on bronchial biopsy 3
- Inhaled corticosteroids are essential for managing persistent inflammation and hyperresponsiveness 3
- Complete avoidance of re-exposure to the causative cleaning agent is mandatory 6
Ongoing Management
Continue high-dose inhaled corticosteroids after the acute episode resolves. The evidence shows that bronchial hyperresponsiveness and airway inflammation can persist despite symptomatic improvement 3. Monitor with:
- Peak flow measurements 4 times daily
- Oximetry maintaining SaO₂ >92%
- Reassess PEF 15-30 minutes after each bronchodilator dose 2
Critical Pitfalls to Avoid
- Never use SABA alone - all asthmatics require ICS-containing therapy to reduce exacerbation risk 7, 8
- Do not give sedation - absolutely contraindicated in acute asthma 1
- Avoid antibiotics unless bacterial infection confirmed 1
- Do not delay systemic corticosteroids - underuse is a major factor in preventable asthma deaths 2
- Do not give bolus aminophylline if patient already taking oral theophyllines 1, 2
Discharge Planning
Only discharge when:
- PEF >75% predicted or personal best
- Diurnal PEF variability <25%
- No nocturnal symptoms
- Patient has been on discharge medications for 24 hours 2
Discharge with: